Endovascular stenting for treatment of superior vena cava syndrome [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2009; 37(6): 414-416

Endovascular stenting for treatment of superior vena cava syndrome

Oğuz Karaca1, Mustafa Akçakoyun1, Özlem Esen2, Ali Metin Esen1
1Department of Cardiology, Kartal Koşuyolu Heart Training and Research Hospital, İstanbul
2Department of Cardiology, Memorial Hospital, İstanbul

With the advances in interventional cardiology, percutaneous treatment by stenting has become a reasonable strategy in superior vena cava syndrome (SVCS), whether the underlying disease is malign or benign. We present a 48-year-old woman with typical signs and symptoms of SVCS, who was treated with endovascular stenting by the percutaneous approach. We obtained both procedural success with complete restoration of blood flow and immediate relief of symptoms. During a follow-up period of six months, the patient was free of symptoms and computed tomography demonstrated complete stent patency.

Keywords: Stents, superior vena cava syndrome/etiology/therapy, vascular surgical procedures.

How to cite this article
Oğuz Karaca, Mustafa Akçakoyun, Özlem Esen, Ali Metin Esen. Endovascular stenting for treatment of superior vena cava syndrome. Turk Kardiyol Dern Ars. 2009; 37(6): 414-416

Corresponding Author: Ali Metin Esen, Türkiye
© Copyright 2020 Archives of the Turkish Society of Cardiology
LookUs & Online Makale